$98.82
-0.13-0.13%
At close: -
$99.14
0.320.32%
After Hours: 7:55 PM EDT
Comments
Loading...
Latest news for Merck & Co (NYSE:MRK) Stock
Merck & Co Stock (NYSE: MRK)
Categories: All
Friday, January 31, 2025
Thursday, January 30, 2025
- Noteworthy Insider Activity: Chirfi Guindo Invests $2.76M In Merck & Co Stock
- Chairman Of Merck & Co Makes $9.33M Buy
- EVP & CFO Of Merck & Co Makes $2.29M Buy
- Johannes Oosthuizen's Recent Buy: Acquires $848K In Merck & Co Stock
- Major Purchase Alert: Jennifer Zachary Invests $2.49M In Merck & Co Stock
- Merck Ends PAH Drug Trial Early After Results...
Wednesday, January 29, 2025
Tuesday, January 28, 2025
Monday, January 27, 2025
Friday, January 24, 2025
Thursday, January 23, 2025
Wednesday, January 22, 2025
Tuesday, January 21, 2025
Friday, January 17, 2025
Wednesday, January 15, 2025
Monday, January 13, 2025
Thursday, January 09, 2025
Wednesday, January 08, 2025
- UBS Maintains Buy on Merck & Co, Lowers Price...
- Salesforce To Rally More Than 23%? Here Are 10 Top Analyst Forecasts For Wednesday
- This Adobe Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
- Merck Announced That The National Medical Pro...
- Truist Securities Downgrades Merck & Co to Ho...
Tuesday, January 07, 2025
- Bullish Outlook On Instil Bio's Investigational Cancer Drug: Jefferies Sees Over 300% Stock Upside
- Unpacking the Latest Options Trading Trends in Merck & Co
- Merck Buys WuXi Vaccines' Irish Manufacturing Facility For Over $500 Million
- Merck & Compnay and OPKO Health shares are tr...
- OPKO Health's ModeX Therapeutics Begins Phase...
Monday, January 06, 2025
Thursday, January 02, 2025
Tuesday, December 31, 2024
Wednesday, December 25, 2024
Monday, December 23, 2024
Sunday, December 22, 2024
Friday, December 20, 2024
Thursday, December 19, 2024
- Merck's Investigational Two-Drug Regime For HIV Meets Primary Goal In Two Late-Stage Trials
- Your Healthcare Costs are Soaring! US Spending Reached $5 Trillion In 2023 with Major Increase in Obesity and Diabetes Drugs, Hospital Services
- Stock Of The Day: Where Does The Merck Downtrend End?
- Merck Agrees To Purchase $50M Of Personalis C...
- Merck Announced Topline Results From Two Phas...